Ramiven 150mg Tablet

Ramiven 150 mg Tablet is an anticancer medication containing the active ingredient Abemaciclib. It is indicated for the treatment of certain types of breast cancer that are hormone receptor-positive and HER2 negative, in their advanced or metastatic stages (breast cancer that has spread to other parts of the body). In cancer, cells multiply in an uncontrolled and abnormal manner. This medication works by inhibiting cyclin-dependent kinases, proteins that play a significant role in the rapid multiplication of cancer cells. The medicine is for oral use only and is given in combination with other hormonal medications. Ramiven 150 mg Tablet is not recommended for adolescents and children under 18 years of age. Before taking this medicine, inform your doctor if you have any signs of infections such as fever, chills, or sore throat, or if you have liver or kidney disorders. Inform your doctor if you are pregnant or planning for pregnancy in the near future, as Ramiven 150 mg Tablet may impact fetal development. If you are receiving this treatment during the childbearing age, discuss with your doctor the use of effective birth control methods during treatment and for at least three weeks after the last dose. This medicine may cause fertility problems in men. You must not consume grapefruits or drink grapefruit juice during treatment with Ramiven Tablet. Inform your doctor of all medicines, including supplements and herbal medicines, that you are taking before starting treatment with this medication to avoid serious side effects. Report to your doctor if you have had a history of intolerance to any forms of sugar.

Ramiven 150 mg uses: Advanced or metastatic breast cancer . Advanced or metastatic non-small cell lung cancer . Advanced or metastatic endometrial cancer . Paediatric patients with neuroblastoma.

Ramiven 150mg Tablet works by blocking the activity of CDK4 and CDK6 enzymes, which are involved in cell division and growth. By inhibiting these enzymes, it slows down or stops the growth of cancer cells.

Ramiven 150mg Tablet is usually taken orally, with or without food. The tablets should be swallowed whole with a glass of water and not crushed, chewed, or broken. The dosage and frequency will depend on various factors, including the patient's age, weight, overall health, and the type and stage of the cancer being treated. It's important to follow the dosing instructions provided by a healthcare provider, and not to adjust the dosage or frequency without consulting with them first. If a dose is missed, it should be taken as soon as possible unless it's within 6 hours of the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. It is important not to take a double dose to make up for a missed dose.

Ramiven 150 mg side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious: Dehydration Kidney problem Electrolyte imbalances Liver damage Dark urine Abdominal pain Pneumonitis Interstitial lung disease Chest pain Common: Diarrhoea Nausea Vomiting Fatigue Decreased appetite Abdominal pain Headache Respiratory tract infections Anaemia Increased risk of infections Low white blood cell count Low platelet count

If you have been prescribed Ramiven 150mg Tablet or any other medication, it is important to follow the instructions provided by your healthcare provider and to report any side effects or concerns promptly. It can cause serious side effects, so it is important to monitor your symptoms and seek medical attention if you experience any concerning changes in your health. It is also important to avoid alcohol and to follow any safety recommendations provided by your healthcare provider while taking it. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, it can be an effective treatment option for certain types of cancer.